4
Changes in Ownership
Protagonist Therapeutics, Inc Filed Acc 0001209191-21-010401
Director sold 8,400 shares at an average $25.30 ($212,555)
- Director acquired 8,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Noonberg Sarah B. · Director
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-10 | Grant or award : show line 1 in the form | +4,700 | $6.98 | $32,806 | 4,700 | D |
| 2021-02-10 | Sale : show line 2 in the form | −4,300 | $25.42 | $109,306 | 400 | D |
| 2021-02-10 | Sale : show line 3 in the form | −400 | $26.04 | $10,416 | 0 | D |
| 2021-02-11 | Grant or award : show line 4 in the form | +3,700 | $6.98 | $25,826 | 3,700 | D |
| 2021-02-11 | Sale : show line 5 in the form | −3,700 | $25.09 | $92,833 | 0 | D |
| Open-market sales · 8,400 sh · avg $25.30 · $212,555 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-10 | Exercise or conversion : show line 6 in the form Stock Option (right to buy) | −4,700 | 7,300 | D |
| 2021-02-11 | Exercise or conversion : show line 7 in the form Stock Option (right to buy) | −3,700 | 3,600 | D |
Loading xslF345X03/doc4.xml…